Oosterhuis B, ten Berge I J, Schellekens P T, van Boxtel C J
Clinical Pharmacology Section, Academic Medical Center, Amsterdam, The Netherlands.
J Pharmacol Exp Ther. 1987 Nov;243(2):716-22.
In a previous study the feasibility of pharmacokinetic-pharmacodynamic modeling for a quantitative description of the lymphocytopenic effect of prednisolone was demonstrated. We now applied this technique to compare the lymphocytopenia of T-lymphocyte subsets, namely CD8 and CD4. The finding of similar rate constants for the delay of the effect on different T-lymphocyte categories supports the explanation of this delay on the basis of pharmacokinetics rather than cellkinetics. The time course of the responsiveness of remaining lymphocytes in mixed lymphocyte culture after prednisolone administration could be described with the same model as the lymphocytopenia. The concurrence of both effects suggests that total lymphocyte counts, if considered intraindividually, could be used as a measure for monitoring the indirect immunosuppressive effect of prednisolone. The inhibitory effect on mixed lymphocyte culture of plasma from subjects who received prednisolone was directly related with the prednisolone concentrations in plasma. Just as for the indirect effect, a threshold concentration could be observed in the concerning concentration-effect relation. This is attributed to the decrease of endogenous hydrocortisone levels under the influence of prednisolone. Possible consequences of our results and those from related studies for the use of prednisolone as an immunosuppressive drug are discussed.
在之前的一项研究中,已证明药代动力学-药效学建模用于定量描述泼尼松龙淋巴细胞减少效应的可行性。我们现在应用该技术来比较T淋巴细胞亚群(即CD8和CD4)的淋巴细胞减少情况。不同T淋巴细胞类别效应延迟的速率常数相似,这一发现支持基于药代动力学而非细胞动力学来解释这种延迟。泼尼松龙给药后混合淋巴细胞培养中剩余淋巴细胞反应性的时间进程可用与淋巴细胞减少相同的模型来描述。两种效应的一致性表明,如果进行个体内比较,总淋巴细胞计数可作为监测泼尼松龙间接免疫抑制作用的指标。接受泼尼松龙治疗的受试者血浆对混合淋巴细胞培养的抑制作用与血浆中泼尼松龙浓度直接相关。与间接效应一样,在相关的浓度-效应关系中可观察到一个阈值浓度。这归因于泼尼松龙影响下内源性氢化可的松水平的降低。讨论了我们的结果以及相关研究结果对将泼尼松龙用作免疫抑制药物的可能影响。